13F HOLDINGS REPORT
Sio Capital Management, LLC
Quarter ended Q4 2023 · Filed November 14, 2023 · Accession 0001214659-23-014980
Total Value
$323.1M
Positions
52
Other Managers
0
Confidential Omitted
No
Holdings (52)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | LABORATORY CORP AMER HLDGS | 50540R409 | 168,809 | $33.9M | 10.50% |
| 2 | GLOBUS MED INC | GMED | 516,981 | $25.7M | 7.94% |
| 3 | GSK PLC | GLAXF | 509,000 | $18.5M | 5.71% |
| 4 | UNITED THERAPEUTICS CORP DEL | UTHR | 81,606 | $18.4M | 5.71% |
| 5 | THE CIGNA GROUP | 125523100 | 58,226 | $16.7M | 5.16% |
| 6 | GE HEALTHCARE TECHNOLOGIES I | GEHC | 242,308 | $16.5M | 5.10% |
| 7 | BICYCLE THERAPEUTICS PLC | BCYC | 796,933 | $16.0M | 4.96% |
| 8 | PFIZER INC | PFE | 450,700 | $14.9M | 4.63% |
| 9 | ORGANON & CO | OGN | 767,000 | $13.3M | 4.12% |
| 10 | TELEFLEX INCORPORATED | TFX | 64,491 | $12.7M | 3.92% |
| 11 | REGENERON PHARMACEUTICALS | REGN | 15,250 | $12.6M | 3.88% |
| 12 | MEDTRONIC PLC | MDT | 110,780 | $8.7M | 2.69% |
| 13 | EMBECTA CORP | EMBC | 568,294 | $8.6M | 2.65% |
| 14 | HEALTHCARE SVCS GROUP INC | 421906108 | 810,307 | $8.5M | 2.62% |
| 15 | ORTHOFIX MED INC | OFIX | 650,000 | $8.4M | 2.59% |
| 16 | ZIMMER BIOMET HOLDINGS INC | ZBH | 73,400 | $8.2M | 2.55% |
| 17 | TRAVERE THERAPEUTICS INC | TVTX | 884,770 | $7.9M | 2.45% |
| 18 | VIKING THERAPEUTICS INC | VKTX | 595,002 | $6.6M | 2.04% |
| 19 | GRACELL BIOTECHNOLOGIES INC | 38406L103 | 2,081,216 | $6.0M | 1.86% |
| 20 | BRIDGEBIO PHARMA INC | BBIO | 222,947 | $5.9M | 1.82% |
| 21 | CENTESSA PHARMACEUTICALS PLC | CNTA | 756,891 | $4.9M | 1.52% |
| 22 | ARS PHARMACEUTICALS INC | SPRY | 1,105,911 | $4.2M | 1.29% |
| 23 | PROTAGONIST THERAPEUTICS INC | PTGX | 248,127 | $4.1M | 1.28% |
| 24 | KARUNA THERAPEUTICS INC | 48576A100 | 24,129 | $4.1M | 1.26% |
| 25 | REVANCE THERAPEUTICS INC | 761330109 | 342,477 | $3.9M | 1.22% |
| 26 | IMMUNOGEN INC | 45253H101 | 232,751 | $3.7M | 1.14% |
| 27 | MERRIMACK PHARMACEUTICALS IN | 590328209 | 288,466 | $3.6M | 1.10% |
| 28 | SAVARA INC | SVRA | 896,250 | $3.4M | 1.05% |
| 29 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 635,969 | $3.4M | 1.05% |
| 30 | ADC THERAPEUTICS SA | ADCT | 3,294,534 | $3.0M | 0.91% |
| 31 | X4 PHARMACEUTICALS INC | XFOR | 2,599,003 | $2.8M | 0.88% |
| 32 | REVOLUTION MEDICINES INC | RVMDW | 72,700 | $2.0M | 0.62% |
| 33 | IDEAYA BIOSCIENCES INC | IDYA | 74,007 | $2.0M | 0.62% |
| 34 | NYXOAH SA | NYXH | 200,076 | $1.4M | 0.44% |
| 35 | APREA THERAPEUTICS INC | APRE | 280,000 | $1.2M | 0.36% |
| 36 | PRELUDE THERAPEUTICS INC | PRLD | 350,000 | $1.1M | 0.33% |
| 37 | CORBUS PHARMACEUTICALS HLDGS INC | CRBP | 150,000 | $1.0M | 0.31% |
| 38 | REPARE THERAPEUTICS INC | 760273102 | 76,049 | $918,672 | 0.28% |
| 39 | SIGHT SCIENCES INC | SGHT | 246,699 | $831,376 | 0.26% |
| 40 | MODULAR MED INC | MODD | 689,352 | $799,648 | 0.25% |
| 41 | HARPOON THERAPEUTICS INC | 41358P205 | 168,017 | $677,109 | 0.21% |
| 42 | FUSION PHARMACEUTICALS INC | 36118A100 | 246,036 | $639,694 | 0.20% |
| 43 | ASLAN PHARMACEUTICALS LTD | 04522R200 | 254,150 | $477,802 | 0.15% |
| 44 | VANDA PHARMACEUTICALS INC | VNDA | 97,616 | $421,701 | 0.13% |
| 45 | INOGEN INC | INGN | 52,794 | $275,585 | 0.09% |
| 46 | NEXTCURE INC | NXTC | 130,000 | $167,700 | 0.05% |
| 47 | MOLECULIN BIOTECH INC | MBRX | 271,230 | $115,951 | 0.04% |
| 48 | VINCERX PHARMA INC | VNCE | 102,049 | $103,069 | 0.03% |
| 49 | ROCKET PHARMACEUTICALS INC | RCKTW | 400,000 | $69,800 | 0.02% |
| 50 | CAREMAX INC | 14171W103 | 30,741 | $65,171 | 0.02% |
| 51 | HUMACYTE INC | HUMAW | 49,998 | $33,439 | 0.01% |
| 52 | CAREMAX INC | 14171W111 | 12,808 | $2,369 | 0.00% |